Guus Bol, MD, PhD

Publications

  1. Andel D, Ramdhani K, Braat AJAT, Bruijnen RCG, Bol G, Keane G, Lam MGEH, Kranenburg OW, Rinkes IHMB, Hagendoorn J, Smits MLJ. Radiation Lobectomy in Adjunct to Double Vein Embolization to Reach Sufficient Future Liver Remnant in Patients with Colorectal Cancer Liver Metastases: A Case Series. Volume 48 of Issue 3. Cardiovascular and interventional radiology 2024. PMID: 39604694


  2. K. Zwart, M. Braat, F. van der Baan, A. May, J. Roodhart, D. Al-Toma, J. Otten, M. Los,
    T. Oostergo, R. Fijneman, J. van Dodewaard-de Jong, C. Punt, G. Meijer, J. Lagendijk,
    M. Koopman, M. Intven, G. M. Bol. Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with less than 10 metastases: A multicenter pilot study (NCT05375708) Clinical and Translational Radiation Oncology 2024. PMID:


  3. Zwart K, Braat MNGJA, van der Baan FH, May AM, Roodhart JML, Al-Toma D, Otten JMMB, Los M, Oostergo T, Fijneman RJA, van Dodewaard-de Jong JM, Punt CJA, Meijer G, Lagendijk JJW, Koopman M, Intven M, Bol GM. Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708). Volume 49. Clinical and Translational Radiation Oncology 2024. PMID: 39885896


  4. Winnard PT, Vesuna F, Bol GM, Gabrielson KL, Chenevix-Trench G, Ter Hoeve ND, van Diest PJ, Raman V. Targeting RNA helicase DDX3X with a small molecule inhibitor for breast cancer bone metastasis treatment. Volume 604. Cancer letters 2024. PMID: 39306228


  5. Wijnen N, Bruijnen RCG, Thelissen AAB, de Jong HWAM, van Leeuwaarde RS, Hagendoorn J, Bol GM, Smits MLJ. Ablation of Small Liver Metastases Presenting as Foci of Diffusion Restriction on MRI-Results from the Prospective Minimally Invasive Thermal Ablation (MITA) Study. Volume 16 of Issue 13. Cancers 2024. PMID: 39001471


  6. Wijnen N, Bruijnen RCG, Vonken EPA, de Jong HWAM, de Bruijne J, Bol GM, Hagendoorn J, Intven MPW, Smits MLJ. Conventional versus Hepatic Arteriography and C-Arm CT-Guided Ablation of Liver Tumors (HepACAGA): A Comparative Analysis. Volume 16 of Issue 10. Cancers 2024. PMID: 38792003


  7. van Nassau SCMW, Bol GM, van der Baan FH, Roodhart JML, Vink GR, Punt CJA, May AM, Koopman M, Derksen JWG. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand? Volume 25 of Issue 4. Current treatment options in oncology 2024. PMID: 38367182


  8. Wagemans MEHM, Braat AJAT, van Rooij R, Smits MLJ, Bruijnen RCG, Prince JF, Bol GM, de Jong HWAM, Lam MGEH. Lung Mean Dose Prediction in Transarterial Radioembolization (TARE): Superiority of [166Ho]-Scout Over [99mTc]MAA in a Prospective Cohort Study. Volume 47 of Issue 4. Cardiovascular and interventional radiology 2024. PMID: 38326577


  9. Küçükköse E, Baars MJD, Amini M, Schraa SJ, Floor E, Bol GM, Borel Rinkes IHM, Roodhart JML, Koopman M, Laoukili J, Kranenburg O, Vercoulen Y. Stromal localization of inactive CD8+ T cells in metastatic mismatch repair deficient colorectal cancer. Volume 130 of Issue 2. British journal of cancer 2023. PMID: 38042958


  10. Schraa SJ, Stelloo E, Laclé MM, Swennenhuis JF, Brosens LAA, Fijneman RJA, Feitsma H, Koopman M, de Leng WW, Vink GR, Bol GM. Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer. Volume 482 of Issue 6. Virchows Archiv : an international journal of pathology 2023. PMID: 37067589


  11. Zwart K, Ruigrok D, de Graaf-Bos M, Goldschmeding R, Koopman M, Bol GM. Spontaneous Complete Regression of Colon Cancer Liver Metastases in a Lung Transplant Patient: A Case Report. Volume 2023. Case reports in transplantation 2023. PMID: 36685719


  12. Strating E, Wassenaar E, Verhagen M, Rauwerdink P, van Schelven S, de Hingh I, Rinkes IB, Boerma D, Witkamp A, Lacle M, Fodde R, Volckmann R, Koster J, Stedingk K, Giesel F, de Roos R, Poot A, Bol G, Lam M, Elias S, Kranenburg O. Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by 68Ga-FAPI-PET imaging. Volume 127 of Issue 1. British journal of cancer 2022. PMID: 35296803


  13. van Nassau SC, Bond MJ, Scheerman I, van Breeschoten J, Kessels R, Valkenburg-van Iersel LB, Verheul HM, Buffart TE, Mekenkamp LJ, Lemmens VE, Koopman M, Bol GM, EXCITE (From Clinical Trial to Bedside: Triplet Chemotherapy in Metastatic Colorectal Cancer) Study. Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer. Volume 4 of Issue 9. JAMA network open 2021. PMID: 34505885


  14. J. H. J. M. van Krieken, R. G. H. Beets-Tan, Gelderblom, M. J. J. O. van Acht, H. J. T.
    Rutten. Leerboek oncologie ch. 12. paraneoplastische syndromen ch. 21. Tumoren van dunne en dikke darm 2020. PMID:


  15. Chargi N, Ansari E, Huiskamp LFJ, Bol G, de Bree R. Agreement between skeletal muscle mass measurements using computed tomography imaging and magnetic resonance imaging in head and neck cancer patients. Volume 99. Oral oncology 2019. PMID: 31253538


  16. Kerr CL, Bol GM, Vesuna F, Raman V. Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation. Volume 10 of Issue 1-2. Genes & cancer 2019. PMID: 30899416


  17. Heerma van Voss MR, Vesuna F, Bol GM, Afzal J, Tantravedi S, Bergman Y, Kammers K, Lehar M, Malek R, Ballew M, Ter Hoeve N, Abou D, Thorek D, Berlinicke C, Yazdankhah M, Sinha D, Le A, Abrahams R, Tran PT, van Diest PJ, Raman V. Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment. Volume 37 of Issue 1. Oncogene 2017. PMID: 28869602


  18. Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V. Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer. Volume 10. OncoTargets and therapy 2017. PMID: 28761359


  19. Heerma van Voss MR, Brilliant JD, Vesuna F, Bol GM, van der Wall E, van Diest PJ, Raman V. Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer. Volume 34 of Issue 3. Medical oncology (Northwood, London, England) 2017. PMID: 28138868


  20. Xie M, Vesuna F, Tantravedi S, Bol GM, Heerma van Voss MR, Nugent K, Malek R, Gabrielson K, van Diest PJ, Tran PT, Raman V. RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3. Volume 76 of Issue 21. Cancer research 2016. PMID: 27634756


  21. Liebregts M, Bol GM, Groen JW, Lieuw-a-Fa M, Heijmen RH, ten Berg JM. FOLFOX chemotherapy as a cause of ventricular septal rupture after alcohol septal ablation for obstructive hypertrophic cardiomyopathy? Volume 207. International journal of cardiology 2016. PMID: 26803246


  22. Bol GM, Xie M, Raman V. DDX3, a potential target for cancer treatment. Volume 14. Molecular cancer 2015. PMID: 26541825


  23. Xie M, Vesuna F, Botlagunta M, Bol GM, Irving A, Bergman Y, Hosmane RS, Kato Y, Winnard PT, Raman V. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3. Volume 6 of Issue 30. Oncotarget 2015. PMID: 26337079


  24. Bol GM, Khan R, Heerma van Voss MR, Tantravedi S, Korz D, Kato Y, Raman V. PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3. Volume 76 of Issue 4. Cancer chemotherapy and pharmacology 2015. PMID: 26330329


  25. Bol GM, Vesuna F, Xie M, Zeng J, Aziz K, Gandhi N, Levine A, Irving A, Korz D, Tantravedi S, Heerma van Voss MR, Gabrielson K, Bordt EA, Polster BM, Cope L, van der Groep P, Kondaskar A, Rudek MA, Hosmane RS, van der Wall E, van Diest PJ, Tran PT, Raman V. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy. Volume 7 of Issue 5. EMBO molecular medicine 2015. PMID: 25820276


  26. Bol GM, Raman V, van der Groep P, Vermeulen JF, Patel AH, van der Wall E, van Diest PJ. Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer. Volume 8 of Issue 5. PloS one 2013. PMID: 23696831


  27. Bijron JG, Bol GM, Verheijen RH, van Diest PJ. Epigenetic biomarkers in the diagnosis of ovarian cancer. Volume 6 of Issue 5. Expert opinion on medical diagnostics 2012. PMID: 23480807


  28. Botlagunta M, Krishnamachary B, Vesuna F, Winnard PT, Bol GM, Patel AH, Raman V. Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells. Volume 6 of Issue 3. PloS one 2011. PMID: 21448281


  29. Kondaskar A, Kondaskar S, Kumar R, Fishbein JC, Muvarak N, Lapidus RG, Sadowska M, Edelman MJ, Bol GM, Vesuna F, Raman V, Hosmane RS. Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System. Volume 2 of Issue 3. ACS medicinal chemistry letters 2010. PMID: 21572541


  30. Bol GM, van Diest PJ. BRCA1 methylation and BRCA1 mutations in ovarian cancer. Volume 122 of Issue 2. Gynecologic oncology 2010. PMID: 21194739


  31. Bol GM, Suijkerbuijk KP, Bart J, Vooijs M, van der Wall E, van Diest PJ. Methylation profiles of hereditary and sporadic ovarian cancer. Volume 57 of Issue 3. Histopathology 2010. PMID: 20840667


  32. G.M. Bol. Homeless people in San Francisco The Lancent Student 2008. PMID: